sec filing
IB
AMEX · IBO
Impact BioMedical Inc.
Healthcare · Biotechnology
$3.80
Down-$0.07 (-1.81%)
Updated Nov 1, 2026, 3:58 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 6.1M
- P/E ratio
- -0.15
- Dividend yield
- 0.00%
- 52-week range
- $0.37 – $7.70
- Volume
- 15.29K
- Avg. volume
- 143.99K
Price performance · IBO
IBO price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
IBO closed at $3.80 after 20 trading sessions, down 21.49% for the selected period.
- Last close
- $3.80
- Period change
- -21.49%
- Period low
- $2.68
- Period high
- $4.84
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $3.52 | $4.10 | $3.52 | $3.80 | 15.29K |
| Oct 29, 2026 | $4.25 | $4.25 | $3.71 | $3.87 | 23.86K |
| Oct 28, 2026 | $3.40 | $4.38 | $3.40 | $3.9899 | 39.89K |
| Oct 27, 2026 | $3.78 | $4.11 | $3.55 | $3.55 | 12.27K |
| Oct 26, 2026 | $3.74 | $3.88 | $3.10 | $3.73 | 12.61K |
| Oct 23, 2026 | $3.69 | $4.0198 | $3.54 | $3.60 | 11.83K |
| Oct 22, 2026 | $3.82 | $4.23 | $3.60 | $3.80 | 21.55K |
| Oct 21, 2026 | $3.60 | $4.32 | $3.60 | $4.02 | 27.68K |
| Oct 20, 2026 | $2.78 | $3.42 | $2.6738 | $3.2675 | 12.34K |
| Oct 19, 2026 | $2.66 | $3.75 | $2.66 | $3.06 | 47.95K |
| Oct 16, 2026 | $3.21 | $3.21 | $2.43 | $2.68 | 10.21K |
| Oct 15, 2026 | $3.17 | $4.08 | $2.62 | $3.1584 | 29.04K |
| Oct 14, 2026 | $3.59 | $3.85 | $3.2501 | $3.4034 | 3.97K |
| Oct 13, 2026 | $4.11 | $4.11 | $3.84 | $3.98 | 9.48K |
| Oct 12, 2026 | $4.25 | $4.46 | $4.00 | $4.03 | 7.39K |
| Oct 9, 2026 | $4.13 | $4.39 | $4.13 | $4.25 | 4.03K |
| Oct 8, 2026 | $4.32 | $4.41 | $4.06 | $4.11 | 17.56K |
| Oct 7, 2026 | $4.57 | $4.59 | $4.36 | $4.48 | 10.74K |
| Oct 6, 2026 | $5.00 | $5.05 | $4.43 | $4.68 | 21.17K |
| Oct 5, 2026 | $5.16 | $5.42 | $4.84 | $4.84 | 17.34K |
Latest IBO news
The latest Smart Investors Daily articles mentioning IBO.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

